Résumé
L’ovaire n’existe pas en tant qu’entité isolée: il appartient à une patiente unique, et originale tant dans les réactions de son organisme que dans ses interactions avec son milieu familial voire socioculturel.
This is a preview of subscription content, log in via an institution to check access.
Preview
Unable to display preview. Download preview PDF.
Références
Koning AM, Mutsaerts MA, Kuchenbecker WK et al (2012) Complications and outcome of assisted reproduction technologies in overweight and obese women. Human Reprod 27: 457–67
Clark AM, Ledger W, Galletly C et al. (1995) Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Human Reprod 10:2705–12
Cheang KI, Nestler JE (2004) Should insulin-sensitizing drugs be used in the treatment of polycystic ovary syndrome? Reprod Biomed Online 8: 440–7
Block E (1952) Quantitative morphological investigations of the follicular system in women: variations at different ages. Acta Anat 14: 108–23
White Yar, Woods DC, Yashushi-Takai I et al. (2012) Oocyte formation by mitotically active germ cells purified from ovaries of reproductive-age women. Nature Medicine 18: 413–21
Luna M, Grunfeld L, Mukherjee T, et al. (2007) Moderatelely elevetated levels of basal follicle-stimulating hormone in young patients predict low ovarian response, but should not be used to disqualify patients from attempting in vitro fertilization. Fertil Steril 87: 782–7
Toner JP (2003) Age = egg quality, FSH level = egg quantity. Fertil Steril 79: 491
Merviel P, Lourdel E, Cabry R et al. (2009) L’exploration de la réserve ovarienne dans le bilan d’infertilité. La Lettre du Gynécologue 343: 31–6
Netter A, Salomon Bernard Y, Millet D (1968) Test de stimulation ovarienne par les HMG. In: Les Gonadotrophines d’origine humaine, Byla-Searle Ed, Paris, p. 31-41
Franchin R, Schonauer LM, Gighini C et al. (2003) Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, œstradiol, FSH and LH on day 3. Hum Reprod 18: 323–7
Berwanger DA, Silva AL, Even M, Grynberg M, et al. (2010) Hormone antimullérienne: acteur et marqueur de la folliculogenèse. Gynecol Obstet Fertil 38: 471–4
Loh JS, Maheshwari A (2011) Anti-Müllerian hormone — is it a crystal ball for predicting ovarian ageing? Hum Reprod 26: 2925–32
Hall JE, Welt CK, Cramer DW (1999) Inhibin A and Inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome. Hum Reprod 14: 409–15
Dewailly D, Gronier H, Poncelet E, et al. (2011) Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on untrasound and the serum AMH levels for the definition of polycystic ovaries. Hum Reprod 26: 3123–29
Muttukrishna S, Mc Garrigle H, Wakim R, et al. (2005) Antral follicle count, antimullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology? BJOG 112: 1384–90
Klinkert ER, Broekmans F, Looman CV, et al. (2005) The antral count is a better marker than basal follicle-stimulating hormone for the selection of older patients with acceptable pregnancy prospects after in vitro fertilization. Fertil Steril 83: 811–14
Syrop CH, Dawson JD, Husman KJ, et al. (1999) Ovarian volume may predict assisted reproductive outcomes better than follicle stimulating hormone concentration on day 3. Hum Reprod 14: 1752–56
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag France
About this chapter
Cite this chapter
Emperaire, JC. (2013). Les préalables à la stimulation. In: Pratique de la stimulation ovulatoire par les gonadotrophines. Springer, Paris. https://doi.org/10.1007/978-2-8178-0398-2_4
Download citation
DOI: https://doi.org/10.1007/978-2-8178-0398-2_4
Publisher Name: Springer, Paris
Print ISBN: 978-2-8178-0397-5
Online ISBN: 978-2-8178-0398-2
eBook Packages: MedicineMedicine (R0)